US00857U2069
US00857U2069
agilon health, inc.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 1.38B EUR | 1.8B EUR | 131.35M EUR | 285.75M EUR |
Enterprise Value | 1.27B EUR | 1.73B EUR | 24.77M EUR | 148.85M EUR |
Valuation Multiples | ||||
Trailing P/E | -- | -- | -- | -- |
Forward P/E | 34.31x | -- | -- | -- |
Price to Sales | 0.23x | 0.3x | 0.02x | 0.06x |
Price to Book | 6.08x | 7.91x | 0.72x | 2.25x |
EV/Revenue | 0.22x | 0.29x | 0x | 0.03x |
EV/EBITDA | -5.3x | -- | -- | -- |
Price to FCF (P/FCF) | -- | -- | -- | -- |
EV/FCF | -- | -- | -- | -- |
FCF Yield | -10.53% | -5.89% | -65.01% | -37.1% |